Premium
Another Challenge for the Presumed Safety Advantage of Bare Metal Stents
Author(s) -
Vetrovec George W.
Publication year - 2015
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.25844
Subject(s) - medicine , conventional pci , stent , randomized controlled trial , revascularization , surgery , intensive care medicine , myocardial infarction
Key Points Compared to BMS, DES may pose no greater and likely less cardiovascular risk particularly after 90 days post‐implantation for patients undergoing noncardiac surgery (NCS) post‐PCI. Optimal peri‐surgical antiplatelet and general risk (Statins etc) management remains to be specifically defined. A creative, prospective, and ideally randomized trial of DES vs. BMS is needed in high‐risk patients with well defined need for pre‐operative PCI utilizing standardized adjunctive medical management. While this analysis focuses on the comparative risk of DES vs. BMS, it remains clear that serious and even fatal events occur in patients undergoing NCS post particularly recent PCI regardless of stent type, thus re‐emphasizing the importance of risk assessment regarding need for pre‐operative PCI revascularization and the timing of NCS post PCI. © 2014 Wiley Periodicals, Inc.